Prediction: Poet Technologies Will Trade at This Price in 2027

POET Technologies (NASDAQ:POET) builds optical interposers and photonic engines that let hyperscale data centers move data with light instead of copper. Revenue jumped 201.86% year over year in Q1 2026, yet shares are stuck at $8.33. Can POET shares hit $25 by 2027?

Why POET Shares Are Stuck Despite Explosive Revenue Growth

The setup looks bullish on paper. POET is up 18.01% YTD, but the recent price action has broken down badly: down 6.63% in the past week and down 38.52% over the past month.

Multiple class action complaints filed in late June 2026 allege POET misrepresented its Passive Foreign Investment Company status, and separate filings tie in a confidentiality breach by CFO Thomas Mika that reportedly caused Celestial AI (now part of Marvell) to cancel purchase orders.

CEO Mika announced his retirement on July 8, 2026. Add a $400 million direct offering announced July 8 and dilution fear stacks on governance fear. Beta of 0.764 understates the actual volatility here.

Wall Street Sees Roughly 110% Upside. Our Model Says More

The Street’s consensus 12-month target sits at $17.50, backed by one Buy rating, zero Holds, and zero Sells. Bullish sentiment among covering analysts is 100%. Our base case for 2027 is more aggressive at $22.23, implying 166.87% upside, with a bull case of $22.89 and a bear case of $16.61. Confidence on that base case is moderate at 0.5.

Wall Street anchors too heavily on the single covering analyst and ignores the Lumilens deal’s optionality. With only one sell-side voice, the consensus is thin. That gap is exactly why a $25 stretch target is worth stress testing.

The Path to $25 Per Share

Reaching $25 from today’s price of $8.33 would require a gain of 200.1%. With forward EPS of -$0.88, a price of $25 implies a forward P/E of -28x. That number is not usable in a traditional sense because POET is not yet profitable. The story rests on revenue scale rather than P/E compression.

The bull thesis: POET converts its Lumilens design win into recurring revenue as its Malaysia facility ramps to high-volume 800G production in Q3 2026 and targets more than 30,000 optical engine shipments in 2026.

CEO Suresh Venkatesan called it “an important commercial milestone… establishes the framework for what we believe could become a substantial long-term supplier relationship supporting frontier AI infrastructure”.

Risk: continued dilution or a customer qualification miss guts the ramp.

Where POET Trades Today vs Its Earnings Power

POET is a revenue-scale story, not yet a P/E story. It trades at a price-to-book multiple of about 3x, below the semiconductor industry average, with roughly $430 million in cash providing runway.

Shares sit inside a 52-week range of $3.87 to $20.81, closer to the lows than the highs. The 10-year total return is a modest 10.78%. It is a call option on Malaysia execution and AI networking demand. If the 800G ramp lands and Lumilens scales, the current market cap looks small versus the revenue POET could book by late 2027.

Is $25 Realistic? Here’s My Take

Hitting $25 by 2027 requires a gain of 200.1% from here, a stretch scenario rather than a base case.

Three things need to go right: the Malaysia facility must hit high-volume 800G production on schedule, Lumilens must convert its $50 million initial order into follow-on business, and the class action overhang must fade. What derails it is another dilutive raise before revenue scales. We’ve outlined the blueprint for how Poet Technologies could reach $25 in 2027.

Contact [email protected] for any questions or corrections.